(UPDATE) Ixazomib (Ninlaro)
Carfilzomib
(UPDATE) Daratumumab (MM)
Elotuzumab
ASCO: COVID-19 Medical Resources
ASH: COVID-19 Resources for Managing Blood Cancers
NCCN Guidelines for Patients: Multiple Myeloma
International Myeloma Foundation (IMF)